139 related articles for article (PubMed ID: 5711258)
21. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
Denber HC
Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
[No Abstract] [Full Text] [Related]
22. [Radioprotective properties of butyrophenone derivatives].
Uray Z; Farcasanu M; Maniu M
Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665
[No Abstract] [Full Text] [Related]
23. Drug therapy.
Stone WN; Hofling CK; Winslow WW
Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
[No Abstract] [Full Text] [Related]
24. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
Vinci M
Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
[No Abstract] [Full Text] [Related]
25. Sympatholytic treatment of "paralytic" ileus.
Petri G; Szenohradszky J; Porszasz-Gibiszer K
Surgery; 1971 Sep; 70(3):359-67. PubMed ID: 5568520
[No Abstract] [Full Text] [Related]
26. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
Madalena JC
Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
[No Abstract] [Full Text] [Related]
27. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
Tetreault L; Filotto J; Bordeleau JM
Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
[No Abstract] [Full Text] [Related]
28. Electroencephalographic effects of trifluperidol.
Itil T; Fink M
Dis Nerv Syst; 1969 Aug; 30(8):524-30. PubMed ID: 5809787
[No Abstract] [Full Text] [Related]
29. [Diagnosis and therapy of the secondary disease: psychiatry].
Burchard JM
Int J Clin Pharmacol; 1973 Dec; 8(4):333-6. PubMed ID: 4150765
[No Abstract] [Full Text] [Related]
30. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
[No Abstract] [Full Text] [Related]
31. Letter: Buronil in Huntington's chorea.
Mattsson B; Boman K
Lancet; 1974 Nov; 2(7892):1323. PubMed ID: 4139562
[No Abstract] [Full Text] [Related]
32. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
33. [Aspects of psychopharmacological treatment of personality disorders].
Meiu G; Ionescu G
Neurol Psihiatr Neurochir; 1974; 19(1):39-49. PubMed ID: 4150968
[No Abstract] [Full Text] [Related]
34. The use of psychopharmacological drugs in the aged.
Webb WL
Geriatrics; 1971 Jun; 26(6):94-103. PubMed ID: 5087975
[No Abstract] [Full Text] [Related]
35. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
Angus JW; Go SH; Simpson GM
Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
[No Abstract] [Full Text] [Related]
36. Effects of haloperidol and trifluperidol on the sleep cycle of the cat.
Monti JM
Electroencephalogr Clin Neurophysiol; 1970 May; 28(5):518. PubMed ID: 4192820
[No Abstract] [Full Text] [Related]
37. A pilot study of AL-1021 in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
[No Abstract] [Full Text] [Related]
38. Risks vs. benefits of antipsychotic drugs.
Baldessarini RJ; Lipinski JF
N Engl J Med; 1973 Aug; 289(8):427-8. PubMed ID: 4146359
[No Abstract] [Full Text] [Related]
39. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
Janssen PA; Allewijn FT
Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
[No Abstract] [Full Text] [Related]
40. A PILOT STUDY OF FLOROPIPAMIDE (DIPIPERON).
SUGERMAN AA
Dis Nerv Syst; 1964 Jun; 25():355-8. PubMed ID: 14169479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
